Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MLYCD | O95822 | 2/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22272369 | 0.79 | — | — | |
| SCHEMBL124304 | 0.79 | — | — | |
| Acetonitrile SCHEMBL19611744 | 0.75 | ALDH1A1 (0.35) | — | |
| Trifluoroacetic Acid SCHEMBL27762565 | 0.74 | TSHR (0.39) | MLYCDMEN1KMT2A | |
| Trifluoroacetic Acid SCHEMBL4182370 | 0.72 | ALDH1A1 (0.35) | — | |
| Trifluoroacetic Acid SCHEMBL4069871 | 0.72 | ALDH1A1 (0.35) | — | |
| Trifluoroacetic Acid SCHEMBL1024065 | 0.71 | MEN1 (0.35) | MLYCDMEN1KMT2A | |
| Trifluoroacetic Acid SCHEMBL30054036 | 0.71 | TSHR (0.58) | MLYCDMEN1KMT2A | |
| Trifluoroacetic Acid SCHEMBL23043751 | 0.71 | ALDH1A1 (0.47) | MLYCDMEN1KMT2A | |
| Trifluoroacetic Acid SCHEMBL27350364 | 0.71 | ALDH1A1 (0.47) | MLYCDMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10933025-B2 | Nanoparticles for encapsulating compounds, the preparation and uses thereof | INNOUP FARMA, S.L. (ES) | 2021-03-02 | — | — | US | disclosed |
| US-20170326074-A1 | NANOPARTICLES FOR ENCAPSULATING COMPOUNDS, THE PREPARATION AND USES THEREOF | INNOUP FARMA, S.L. (ES) | 2017-11-16 | — | — | US | disclosed |
| EP-3233126-A1 | NANOPARTICLES FOR ENCAPSULATING COMPOUNDS, THE PREPARATION AND USES THEREOF | Innoup Farma, S.L. (ES) | 2017-10-25 | — | — | EP | disclosed |
| WO-2016087340-A1 | NANOPARTICLES FOR ENCAPSULATING COMPOUNDS, THE PREPARATION AND USES THEREOF | INNOUP FARMA, S.L. (ES) | 2016-06-09 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170326074-A1 | NANOPARTICLES FOR ENCAPSULATING COMPOUNDS, THE PREPARATION AND USES THEREOF | NCL, CD47, DSTN | MLYCD 3316/4885MEN1 1753/4885KMT2A 3388/4885 |
| US-10933025-B2 | Nanoparticles for encapsulating compounds, the preparation and uses thereof | NCL, CD47, DSTN | MLYCD 3316/4885MEN1 1753/4885KMT2A 3388/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.